 content-type="parsed"><title>References</title><ref id="B1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlenstiel</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Edlich</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hogdal</surname><given-names>LJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rotman</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Noureddin</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feld</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Holz</surname><given-names>LE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Titerence</surname><given-names>RH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>TJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rehermann</surname><given-names>B</given-names></name></person-group>
<year>2011</year>
<article-title>Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C</article-title>. <source>Gastroenterology</source><volume>141</volume>(<issue>4</issue>):<fpage>1231</fpage>&#x02013;<lpage>1239</lpage>, 1239 e1&#x02013;e2<pub-id pub-id-type="pmid">21741920</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahlenstiel</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Titerence</surname><given-names>RH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koh</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Edlich</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feld</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rotman</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghany</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hoofnagle</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>TJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heller</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rehermann</surname><given-names>B</given-names></name></person-group>
<year>2010</year>
<article-title>Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner</article-title>. <source>Gastroenterology</source><volume>138</volume>(<issue>1</issue>):<fpage>325</fpage>&#x02013;<lpage>335 e1&#x02013;e2</lpage><pub-id pub-id-type="pmid">19747917</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>LR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gigliotti Rothfuchs</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roffe</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheever</surname><given-names>AW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bafica</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salazar</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sher</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title>. <source>J Clin Invest</source><volume>120</volume>(<issue>5</issue>):<fpage>1674</fpage>&#x02013;<lpage>1682</lpage><pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brockstedt</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meyer-Morse</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Riordan</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>
<year>2004</year>
<article-title>Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes</article-title>. <source>J Exp Med</source><volume>200</volume>(<issue>4</issue>):<fpage>527</fpage>&#x02013;<lpage>533</lpage><pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bahl</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huebner</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Davis</surname><given-names>RJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>
<year>2010</year>
<article-title>Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonists</article-title>. <source>J Virol</source><volume>84</volume>(<issue>10</issue>):<fpage>4866</fpage>&#x02013;<lpage>4877</lpage><pub-id pub-id-type="pmid">20200235</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gelderblom</surname><given-names>HC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Humphreys</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Semmo</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reesink</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beld</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>van Lier</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klenerman</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>Cellular immune responses during high-dose interferon-alpha induction therapy for hepatitis C virus infection</article-title>. <source>J Infect Dis</source><volume>199</volume>(<issue>6</issue>):<fpage>819</fpage>&#x02013;<lpage>828</lpage><pub-id pub-id-type="pmid">19434929</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baskin</surname><given-names>CR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bielefeldt-Ohmann</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sabourin</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Long</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tolnay</surname><given-names>AE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Albrecht</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pyles</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Olson</surname><given-names>PH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aicher</surname><given-names>LD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rosenzweig</surname><given-names>ER</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Murali-Krishna</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clark</surname><given-names>EA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kotur</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fornek</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Proll</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Palermo</surname><given-names>RE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sabourin</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katze</surname><given-names>MG</given-names></name></person-group>
<year>2009</year>
<article-title>Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>106</volume>(<issue>9</issue>):<fpage>3455</fpage>&#x02013;<lpage>3460</lpage><pub-id pub-id-type="pmid">19218453</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beilharz</surname><given-names>MW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cummins</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bennett</surname><given-names>AL</given-names></name></person-group>
<year>2007</year>
<article-title>Protection from lethal influenza virus challenge by oral type 1 interferon</article-title>. <source>Biochem Biophys Res Commun</source><volume>355</volume>(<issue>3</issue>):<fpage>740</fpage>&#x02013;<lpage>744</lpage><pub-id pub-id-type="pmid">17316562</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benedict</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ware</surname><given-names>CF</given-names></name></person-group>
<year>2012</year>
<article-title>TRAIL: not just for tumors anymore?</article-title><source>J Exp Med</source><volume>209</volume>(<issue>11</issue>):<fpage>1903</fpage>&#x02013;<lpage>1906</lpage><pub-id pub-id-type="pmid">23091198</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bernardo</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cosgaya</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aranda</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jimenez-Lara</surname><given-names>AM</given-names></name></person-group>
<year>2013</year>
<article-title>Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells</article-title>. <source>Cell Death Dis</source><volume>4</volume>:<fpage>e479</fpage><pub-id pub-id-type="pmid">23370279</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graham</surname><given-names>CM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bloch</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oni</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Banchereau</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Skinner</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quinn</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blankenship</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dhawan</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cush</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mejias</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ramilo</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kon</surname><given-names>OM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pascual</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Banchereau</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chaussabel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group>
<year>2010</year>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source><volume>466</volume>(<issue>7309</issue>):<fpage>973</fpage>&#x02013;<lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katlinski</surname><given-names>KV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reichert</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Takano</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brice</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yu</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carbone</surname><given-names>CJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katlinskaya</surname><given-names>YV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leu</surname><given-names>NA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McCorkell</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Girondo</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rui</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>May</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Avadhani</surname><given-names>NG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rustgi</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>SY</given-names></name></person-group>
<year>2014</year>
<article-title>Triggering ubiquitination of IFNAR1 protects tissues from inflammatory injury</article-title>. <source>EMBO Mol Med</source><volume>6</volume>(<issue>3</issue>):<fpage>384</fpage>&#x02013;<lpage>397</lpage><pub-id pub-id-type="pmid">24480543</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binder</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fehr</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hengartner</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group>
<year>1997</year>
<article-title>Virus-induced transient bone marrow aplasia: major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus</article-title>. <source>J Exp Med</source><volume>185</volume>(<issue>3</issue>):<fpage>517</fpage>&#x02013;<lpage>530</lpage><pub-id pub-id-type="pmid">9053452</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graham</surname><given-names>CM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oni</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rozakeas</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rossello-Urgell</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chaussabel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Banchereau</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pascual</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lipman</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title>. <source>PLoS One</source><volume>7</volume>(<issue>10</issue>):<fpage>e46191</fpage><pub-id pub-id-type="pmid">23056259</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boni</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laccabue</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lampertico</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giuberti</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vigano</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schivazappa</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alfieri</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pesci</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gaeta</surname><given-names>GB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brancaccio</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Missale</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>C</given-names></name></person-group>
<year>2012</year>
<article-title>Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues</article-title>. <source>Gastroenterology</source><volume>143</volume>(<issue>4</issue>):<fpage>963</fpage>&#x02013;<lpage>973 e9</lpage><pub-id pub-id-type="pmid">22796241</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boon</surname><given-names>AC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>deBeauchamp</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hollmann</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Luke</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kotb</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rowe</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Finkelstein</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neale</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lu</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williams</surname><given-names>RW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Webby</surname><given-names>RJ</given-names></name></person-group>
<year>2009</year>
<article-title>Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice</article-title>. <source>J Virol</source><volume>83</volume>(<issue>20</issue>):<fpage>10417</fpage>&#x02013;<lpage>10426</lpage><pub-id pub-id-type="pmid">19706712</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bosinger</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>SN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klatt</surname><given-names>NR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Duan</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Francella</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sidahmed</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smith</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cramer</surname><given-names>EM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zeng</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Masopust</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carlis</surname><given-names>JV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ran</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vanderford</surname><given-names>TH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Paiardini</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Isett</surname><given-names>RB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Else</surname><given-names>JG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staprans</surname><given-names>SI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Silvestri</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haase</surname><given-names>AT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelvin</surname><given-names>DJ</given-names></name></person-group>
<year>2009</year>
<article-title>Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys</article-title>. <source>J Clin Invest</source><volume>119</volume>(<issue>12</issue>):<fpage>3556</fpage>&#x02013;<lpage>3572</lpage><pub-id pub-id-type="pmid">19959874</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gong</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Song</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lai</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lin</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ren</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dai</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yin</surname><given-names>Y</given-names></name></person-group>
<year>2014</year>
<article-title>Activation of IL-27 signalling promotes development of postinfluenza pneumococcal pneumonia</article-title>. <source>EMBO Mol Med</source><volume>6</volume>(<issue>1</issue>):<fpage>120</fpage>&#x02013;<lpage>140</lpage><pub-id pub-id-type="pmid">24408967</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Calderon</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group>
<year>2004</year>
<article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection</article-title>. <source>J Exp Med</source><volume>200</volume>(<issue>4</issue>):<fpage>535</fpage>&#x02013;<lpage>540</lpage><pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Holland</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Notarangelo</surname><given-names>LD</given-names></name></person-group>
<year>2012</year>
<article-title>Inborn errors of human JAKs and STATs</article-title>. <source>Immunity</source><volume>36</volume>(<issue>4</issue>):<fpage>515</fpage>&#x02013;<lpage>528</lpage><pub-id pub-id-type="pmid">22520845</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Che</surname><given-names>JW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kraft</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Selin</surname><given-names>LK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>
<year>2014</year>
<article-title>Regulatory T cells resist virus infection-induced apoptosis</article-title>. <source>J Virol</source><volume>89</volume>(<issue>4</issue>):<fpage>2112</fpage>&#x02013;<lpage>2120</lpage><pub-id pub-id-type="pmid">25473049</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borozan</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feld</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tannis</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coltescu</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heathcote</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Edwards</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McGilvray</surname><given-names>ID</given-names></name></person-group>
<year>2005</year>
<article-title>Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection</article-title>. <source>Gastroenterology</source><volume>128</volume>(<issue>5</issue>):<fpage>1437</fpage>&#x02013;<lpage>1444</lpage><pub-id pub-id-type="pmid">15887125</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Poon</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lau</surname><given-names>AS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Luk</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lau</surname><given-names>YL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shortridge</surname><given-names>KF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name></person-group>
<year>2002</year>
<article-title>Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?</article-title><source>Lancet</source><volume>360</volume>(<issue>9348</issue>):<fpage>1831</fpage>&#x02013;<lpage>1837</lpage><pub-id pub-id-type="pmid">12480361</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coelho</surname><given-names>LF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Magno de Freitas Almeida</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mennechet</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blangy</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Uze</surname><given-names>G</given-names></name></person-group>
<year>2005</year>
<article-title>Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>102</volume>(<issue>33</issue>):<fpage>11917</fpage>&#x02013;<lpage>11922</lpage><pub-id pub-id-type="pmid">16081539</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>PL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graham</surname><given-names>BS</given-names></name></person-group>
<year>2008</year>
<article-title>Viral and host factors in human respiratory syncytial virus pathogenesis</article-title>. <source>J Virol</source><volume>82</volume>(<issue>5</issue>):<fpage>2040</fpage>&#x02013;<lpage>2055</lpage><pub-id pub-id-type="pmid">17928346</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crome</surname><given-names>SQ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>PA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>KS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>PS</given-names></name></person-group>
<year>2013</year>
<article-title>Natural killer cells regulate diverse T cell responses</article-title>. <source>Trends Immunol</source><volume>34</volume>(<issue>7</issue>):<fpage>342</fpage>&#x02013;<lpage>349</lpage><pub-id pub-id-type="pmid">23601842</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crotta</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mahlakoiv</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Desmet</surname><given-names>CJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Buckwalter</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Albert</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wack</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>Type I and type III interferons drive redundant amplification loops to induce a transcriptional signature in influenza-infected airway epithelia</article-title>. <source>PLoS Pathog</source><volume>9</volume>(<issue>11</issue>):<fpage>e1003773</fpage><pub-id pub-id-type="pmid">24278020</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bedenikovic</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wiesel</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ibberson</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xenarios</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Von Laer</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalinke</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vivier</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jonjic</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group>
<year>2014a</year>
<article-title>Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1</article-title>. <source>Immunity</source><volume>40</volume>(<issue>6</issue>):<fpage>961</fpage>&#x02013;<lpage>973</lpage><pub-id pub-id-type="pmid">24909889</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>HC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>PA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oxenius</surname><given-names>A</given-names></name></person-group>
<year>2014b</year>
<article-title>NK cells regulating T cell responses: mechanisms and outcome</article-title>. <source>Trends Immunol</source>, DOI: <pub-id pub-id-type="doi">10.1016/j.it.2014.11.001</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Crotta</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McCabe</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wack</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Pathogenic potential of interferon alphabeta in acute influenza infection</article-title>. <source>Nat Commun</source><volume>5</volume>:<fpage>3864</fpage><pub-id pub-id-type="pmid">24844667</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Simmons</surname><given-names>CP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thanh</surname><given-names>TT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hien</surname><given-names>VM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smith</surname><given-names>GJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chau</surname><given-names>TN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hoang</surname><given-names>DM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chau</surname><given-names>NV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khanh</surname><given-names>TH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dong</surname><given-names>VC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qui</surname><given-names>PT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cam</surname><given-names>BV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ha do</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chinh</surname><given-names>NT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hien</surname><given-names>TT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Farrar</surname><given-names>J</given-names></name></person-group>
<year>2006</year>
<article-title>Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia</article-title>. <source>Nat Med</source><volume>12</volume>(<issue>10</issue>):<fpage>1203</fpage>&#x02013;<lpage>1207</lpage><pub-id pub-id-type="pmid">16964257</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunn</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brunetto</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Christophides</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>PT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lampertico</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Das</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lopes</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borrow</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williams</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Humphreys</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Afford</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Adams</surname><given-names>DH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bertoletti</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maini</surname><given-names>MK</given-names></name></person-group>
<year>2007</year>
<article-title>Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage</article-title>. <source>J Exp Med</source><volume>204</volume>(<issue>3</issue>):<fpage>667</fpage>&#x02013;<lpage>680</lpage><pub-id pub-id-type="pmid">17353365</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernandez-Sesma</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>CK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rao</surname><given-names>TD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frey</surname><given-names>AB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vukmanovic</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levy</surname><given-names>DE</given-names></name></person-group>
<year>2000</year>
<article-title>Type I IFN modulates innate and specific antiviral immunity</article-title>. <source>J Immunol</source><volume>164</volume>(<issue>8</issue>):<fpage>4220</fpage>&#x02013;<lpage>4228</lpage><pub-id pub-id-type="pmid">10754318</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Durbin</surname><given-names>RK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kotenko</surname><given-names>SV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durbin</surname><given-names>JE</given-names></name></person-group>
<year>2013</year>
<article-title>Interferon induction and function at the mucosal surface</article-title>. <source>Immunol Rev</source><volume>255</volume>(<issue>1</issue>):<fpage>25</fpage>&#x02013;<lpage>39</lpage><pub-id pub-id-type="pmid">23947345</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraietta</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mueller</surname><given-names>YM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boesteanu</surname><given-names>AC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gracias</surname><given-names>DT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Do</surname><given-names>DH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hope</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kathuria</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McGettigan</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewis</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giavedoni</surname><given-names>LD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jacobson</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katsikis</surname><given-names>PD</given-names></name></person-group>
<year>2013</year>
<article-title>Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection</article-title>. <source>PLoS Pathog</source><volume>9</volume>(<issue>10</issue>):<fpage>e1003658</fpage><pub-id pub-id-type="pmid">24130482</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujikura</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chiba</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Muramatsu</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kazumata</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nakayama</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kawai</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kida</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Miyazaki</surname><given-names>T</given-names></name></person-group>
<year>2013</year>
<article-title>Type-I interferon is critical for FasL expression on lung cells to determine the severity of influenza</article-title>. <source>PLoS One</source><volume>8</volume>(<issue>2</issue>):<fpage>e55321</fpage><pub-id pub-id-type="pmid">23408968</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Biron</surname><given-names>CA</given-names></name></person-group>
<year>2006</year>
<article-title>Type 1 interferons and the virus-host relationship: a lesson in detente</article-title>. <source>Science</source><volume>312</volume>(<issue>5775</issue>):<fpage>879</fpage>&#x02013;<lpage>882</lpage><pub-id pub-id-type="pmid">16690858</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durbin</surname><given-names>RK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zheng</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Palese</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gertner</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levy</surname><given-names>DE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durbin</surname><given-names>JE</given-names></name></person-group>
<year>1998</year>
<article-title>The role of interferon in influenza virus tissue tropism</article-title>. <source>J Virol</source><volume>72</volume>(<issue>11</issue>):<fpage>8550</fpage>&#x02013;<lpage>8558</lpage><pub-id pub-id-type="pmid">9765393</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goritzka</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durant</surname><given-names>LR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pereira</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salek-Ardakani</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Openshaw</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Johansson</surname><given-names>C</given-names></name></person-group>
<year>2014</year>
<article-title>Alpha/beta interferon receptor signaling amplifies early proinflammatory cytokine production in the lung during respiratory syncytial virus infection</article-title>. <source>J Virol</source><volume>88</volume>(<issue>11</issue>):<fpage>6128</fpage>&#x02013;<lpage>6136</lpage><pub-id pub-id-type="pmid">24648449</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hahm</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trifilo</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zuniga</surname><given-names>EI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group>
<year>2005</year>
<article-title>Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling</article-title>. <source>Immunity</source><volume>22</volume>(<issue>2</issue>):<fpage>247</fpage>&#x02013;<lpage>257</lpage><pub-id pub-id-type="pmid">15723812</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heim</surname><given-names>MH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thimme</surname><given-names>R</given-names></name></person-group>
<year>2014</year>
<article-title>Innate and adaptive immune responses in HCV infections</article-title>. <source>J Hepatol</source><volume>61</volume>(<issue>1S</issue>):<fpage>S14</fpage>&#x02013;<lpage>S25</lpage><pub-id pub-id-type="pmid">25443342</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herbeuval</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nilsson</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boasso</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hardy</surname><given-names>AW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kruhlak</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anderson</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dolan</surname><given-names>MJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dy</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andersson</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shearer</surname><given-names>GM</given-names></name></person-group>
<year>2006</year>
<article-title>Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>103</volume>(<issue>18</issue>):<fpage>7000</fpage>&#x02013;<lpage>7005</lpage><pub-id pub-id-type="pmid">16632604</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermesh</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moltedo</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lopez</surname><given-names>CB</given-names></name></person-group>
<year>2010</year>
<article-title>Antiviral instruction of bone marrow leukocytes during respiratory viral infections</article-title>. <source>Cell Host Microbe</source><volume>7</volume>(<issue>5</issue>):<fpage>343</fpage>&#x02013;<lpage>353</lpage><pub-id pub-id-type="pmid">20478536</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herold</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Steinmueller</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>von Wulffen</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cakarova</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pinto</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pleschka</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mack</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kuziel</surname><given-names>WA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Corazza</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brunner</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Seeger</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lohmeyer</surname><given-names>J</given-names></name></person-group>
<year>2008</year>
<article-title>Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand</article-title>. <source>J Exp Med</source><volume>205</volume>(<issue>13</issue>):<fpage>3065</fpage>&#x02013;<lpage>3077</lpage><pub-id pub-id-type="pmid">19064696</pub-id></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogner</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wolff</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pleschka</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Plog</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gruber</surname><given-names>AD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalinke</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Walmrath</surname><given-names>HD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bodner</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gattenlohner</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewe-Schlosser</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matrosovich</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Seeger</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lohmeyer</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Herold</surname><given-names>S</given-names></name></person-group>
<year>2013</year>
<article-title>Macrophage-expressed IFN-beta contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia</article-title>. <source>PLoS Pathog</source><volume>9</volume>(<issue>2</issue>):<fpage>e1003188</fpage><pub-id pub-id-type="pmid">23468627</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holoch</surname><given-names>PA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Griffith</surname><given-names>TS</given-names></name></person-group>
<year>2009</year>
<article-title>TNF-related apoptosis-inducing ligand (TRAIL): a new path to anti-cancer therapies</article-title>. <source>Eur J Pharmacol</source><volume>625</volume>(<issue>1&#x02013;3</issue>):<fpage>63</fpage>&#x02013;<lpage>72</lpage><pub-id pub-id-type="pmid">19836385</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isaacs</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lindenmann</surname><given-names>J</given-names></name></person-group>
<year>1957</year>
<article-title>Virus interference. I. The interferon</article-title>. <source>Proc R Soc Lond B Biol Sci</source><volume>147</volume>(<issue>927</issue>):<fpage>258</fpage>&#x02013;<lpage>267</lpage><pub-id pub-id-type="pmid">13465720</pub-id></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Amakawa</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Inaba</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ikehara</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Inaba</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fukuhara</surname><given-names>S</given-names></name></person-group>
<year>2001</year>
<article-title>Differential regulation of human blood dendritic cell subsets by IFNs</article-title>. <source>J Immunol</source><volume>166</volume>(<issue>5</issue>):<fpage>2961</fpage>&#x02013;<lpage>2969</lpage><pub-id pub-id-type="pmid">11207245</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivashkiv</surname><given-names>LB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Donlin</surname><given-names>LT</given-names></name></person-group>
<year>2014</year>
<article-title>Regulation of type I interferon responses</article-title>. <source>Nat Rev Immunol</source><volume>14</volume>(<issue>1</issue>):<fpage>36</fpage>&#x02013;<lpage>49</lpage><pub-id pub-id-type="pmid">24362405</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacquelin</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mayau</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Targat</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liovat</surname><given-names>AS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kunkel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Petitjean</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dillies</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roques</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Butor</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Silvestri</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giavedoni</surname><given-names>LD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lebon</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barre-Sinoussi</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Benecke</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Muller-Trutwin</surname><given-names>MC</given-names></name></person-group>
<year>2009</year>
<article-title>Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response</article-title>. <source>J Clin Invest</source><volume>119</volume>(<issue>12</issue>):<fpage>3544</fpage>&#x02013;<lpage>3555</lpage><pub-id pub-id-type="pmid">19959873</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jolly</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Booth</surname><given-names>NJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neil</surname><given-names>SJ</given-names></name></person-group>
<year>2010</year>
<article-title>Cell-cell spread of human immunodeficiency virus type 1 overcomes tetherin/BST-2-mediated restriction in T cells</article-title>. <source>J Virol</source><volume>84</volume>(<issue>23</issue>):<fpage>12185</fpage>&#x02013;<lpage>12199</lpage><pub-id pub-id-type="pmid">20861257</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalie</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Abramovich</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2007</year>
<article-title>An interferon alpha2 mutant optimized by phage display for IFNAR1 binding confers specifically enhanced antitumor activities</article-title>. <source>J Biol Chem</source><volume>282</volume>(<issue>15</issue>):<fpage>11602</fpage>&#x02013;<lpage>11611</lpage><pub-id pub-id-type="pmid">17310065</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalie</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Podoplelova</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Piehler</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2008</year>
<article-title>The stability of the ternary interferon-receptor complex rather than the affinity to the individual subunits dictates differential biological activities</article-title>. <source>J Biol Chem</source><volume>283</volume>(<issue>47</issue>):<fpage>32925</fpage>&#x02013;<lpage>32936</lpage><pub-id pub-id-type="pmid">18801736</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Delgado</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eshleman</surname><given-names>EM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hill</surname><given-names>KK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Connor</surname><given-names>BP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<year>2013</year>
<article-title>Type I IFNs downregulate myeloid cell IFN-gamma receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription</article-title>. <source>J Immunol</source><volume>191</volume>(<issue>6</issue>):<fpage>3384</fpage>&#x02013;<lpage>3392</lpage><pub-id pub-id-type="pmid">23935197</pub-id></mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchhoff</surname><given-names>F</given-names></name></person-group>
<year>2010</year>
<article-title>Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses</article-title>. <source>Cell Host Microbe</source><volume>8</volume>(<issue>1</issue>):<fpage>55</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="pmid">20638642</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobasa</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jones</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shinya</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kash</surname><given-names>JC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Copps</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ebihara</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hatta</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Halfmann</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hatta</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feldmann</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alimonti</surname><given-names>JB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fernando</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katze</surname><given-names>MG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feldmann</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kawaoka</surname><given-names>Y</given-names></name></person-group>
<year>2007</year>
<article-title>Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus</article-title>. <source>Nature</source><volume>445</volume>(<issue>7125</issue>):<fpage>319</fpage>&#x02013;<lpage>323</lpage><pub-id pub-id-type="pmid">17230189</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koerner</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalinke</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weiss</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>
<year>2007</year>
<article-title>Protective role of beta interferon in host defense against influenza A virus</article-title>. <source>J Virol</source><volume>81</volume>(<issue>4</issue>):<fpage>2025</fpage>&#x02013;<lpage>2030</lpage><pub-id pub-id-type="pmid">17151098</pub-id></mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotenko</surname><given-names>SV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gallagher</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baurin</surname><given-names>VV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewis-Antes</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shen</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shah</surname><given-names>NK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Langer</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sheikh</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dickensheets</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Donnelly</surname><given-names>RP</given-names></name></person-group>
<year>2003</year>
<article-title>IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex</article-title>. <source>Nat Immunol</source><volume>4</volume>(<issue>1</issue>):<fpage>69</fpage>&#x02013;<lpage>77</lpage><pub-id pub-id-type="pmid">12483210</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kudva</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Scheller</surname><given-names>EV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Robinson</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Crowe</surname><given-names>CR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Choi</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Slight</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dubin</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Enelow</surname><given-names>RI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kolls</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alcorn</surname><given-names>JF</given-names></name></person-group>
<year>2011</year>
<article-title>Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice</article-title>. <source>J Immunol</source><volume>186</volume>(<issue>3</issue>):<fpage>1666</fpage>&#x02013;<lpage>1674</lpage><pub-id pub-id-type="pmid">21178015</pub-id></mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kugel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Obojes</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roth</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kobinger</surname><given-names>GP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kobasa</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>von Messling</surname><given-names>V</given-names></name></person-group>
<year>2009</year>
<article-title>Intranasal administration of alpha interferon reduces seasonal influenza A virus morbidity in ferrets</article-title>. <source>J Virol</source><volume>83</volume>(<issue>8</issue>):<fpage>3843</fpage>&#x02013;<lpage>3851</lpage><pub-id pub-id-type="pmid">19193792</pub-id></mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>KG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barriere</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carbone</surname><given-names>CJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baker</surname><given-names>DP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lukacs</surname><given-names>GL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>SY</given-names></name></person-group>
<year>2007</year>
<article-title>Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis</article-title>. <source>J Cell Biol</source><volume>179</volume>(<issue>5</issue>):<fpage>935</fpage>&#x02013;<lpage>950</lpage><pub-id pub-id-type="pmid">18056411</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>KG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krolewski</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>SY</given-names></name></person-group>
<year>2004</year>
<article-title>Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor</article-title>. <source>J Biol Chem</source><volume>279</volume>(<issue>45</issue>):<fpage>46614</fpage>&#x02013;<lpage>46620</lpage><pub-id pub-id-type="pmid">15337770</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bon</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durand</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kamphuis</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thompson</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bulfone-Paus</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rossmann</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalinke</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name></person-group>
<year>2006a</year>
<article-title>Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming</article-title>. <source>J Immunol</source><volume>176</volume>(<issue>8</issue>):<fpage>4682</fpage>&#x02013;<lpage>4689</lpage><pub-id pub-id-type="pmid">16585561</pub-id></mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bon</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thompson</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kamphuis</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durand</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rossmann</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kalinke</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name></person-group>
<year>2006b</year>
<article-title>Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN</article-title>. <source>J Immunol</source><volume>176</volume>(<issue>4</issue>):<fpage>2074</fpage>&#x02013;<lpage>2078</lpage><pub-id pub-id-type="pmid">16455962</pub-id></mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leaman</surname><given-names>DW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chawla-Sarkar</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vyas</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ozdemir</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yi</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williams</surname><given-names>BR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borden</surname><given-names>EC</given-names></name></person-group>
<year>2003</year>
<article-title>Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2</article-title>. <source>J Interferon Cytokine Res</source><volume>23</volume>(<issue>12</issue>):<fpage>745</fpage>&#x02013;<lpage>756</lpage><pub-id pub-id-type="pmid">14769151</pub-id></mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Harari</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2011</year>
<article-title>Stochastic receptor expression determines cell fate upon interferon treatment</article-title>. <source>Mol Cell Biol</source><volume>31</volume>(<issue>16</issue>):<fpage>3252</fpage>&#x02013;<lpage>3266</lpage><pub-id pub-id-type="pmid">21690295</pub-id></mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moltedo</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>
<year>2012</year>
<article-title>Type I interferon induction during influenza virus infection increases susceptibility to secondary <italic>Streptococcus pneumoniae</italic> infection by negative regulation of gammadelta T cells</article-title>. <source>J Virol</source><volume>86</volume>(<issue>22</issue>):<fpage>12304</fpage>&#x02013;<lpage>12312</lpage><pub-id pub-id-type="pmid">22951826</pub-id></mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gao</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Han</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>YH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>W</given-names></name></person-group>
<year>2007</year>
<article-title>Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax</article-title>. <source>J Immunol</source><volume>178</volume>(<issue>1</issue>):<fpage>503</fpage>&#x02013;<lpage>510</lpage><pub-id pub-id-type="pmid">17182590</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez</surname><given-names>CB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yount</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hermesh</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moran</surname><given-names>TM</given-names></name></person-group>
<year>2006</year>
<article-title>Sendai virus infection induces efficient adaptive immunity independently of type I interferons</article-title>. <source>J Virol</source><volume>80</volume>(<issue>9</issue>):<fpage>4538</fpage>&#x02013;<lpage>4545</lpage><pub-id pub-id-type="pmid">16611914</pub-id></mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucifora</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xia</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reisinger</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stadler</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sprinzl</surname><given-names>MF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koppensteiner</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Makowska</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Volz</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Remouchamps</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chou</surname><given-names>WM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thasler</surname><given-names>WE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huser</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Durantel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>TJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Munk</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heim</surname><given-names>MH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Browning</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dejardin</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dandri</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schindler</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heikenwalder</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Protzer</surname><given-names>U</given-names></name></person-group>
<year>2014</year>
<article-title>Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA</article-title>. <source>Science</source><volume>343</volume>(<issue>6176</issue>):<fpage>1221</fpage>&#x02013;<lpage>1228</lpage><pub-id pub-id-type="pmid">24557838</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>JD</given-names></name></person-group>
<year>2012</year>
<article-title>Interferon-inducible effector mechanisms in cell-autonomous immunity</article-title>. <source>Nat Rev Immunol</source><volume>12</volume>(<issue>5</issue>):<fpage>367</fpage>&#x02013;<lpage>382</lpage><pub-id pub-id-type="pmid">22531325</pub-id></mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tsenova</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bergtold</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Freeman</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tovey</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Musser</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name></person-group>, <person-group person-group-type="author"><name><surname>Freedman</surname><given-names>VH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>G</given-names></name></person-group>
<year>2001</year>
<article-title>Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>98</volume>(<issue>10</issue>):<fpage>5752</fpage>&#x02013;<lpage>5757</lpage><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tsenova</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Freeman</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barczak</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tovey</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barry</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>G</given-names></name></person-group>
<year>2005</year>
<article-title>Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>. <source>J Interferon Cytokine Res</source><volume>25</volume>(<issue>11</issue>):<fpage>694</fpage>&#x02013;<lpage>701</lpage><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mandl</surname><given-names>JN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barry</surname><given-names>AP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vanderford</surname><given-names>TH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kozyr</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chavan</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klucking</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barrat</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coffman</surname><given-names>RL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staprans</surname><given-names>SI</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feinberg</surname><given-names>MB</given-names></name></person-group>
<year>2008</year>
<article-title>Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections</article-title>. <source>Nat Med</source><volume>14</volume>(<issue>10</issue>):<fpage>1077</fpage>&#x02013;<lpage>1087</lpage><pub-id pub-id-type="pmid">18806803</pub-id></mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>HD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Urban</surname><given-names>SL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>
<year>2011</year>
<article-title>Virus-induced transient immune suppression and the inhibition of T cell proliferation by type I interferon</article-title>. <source>J Virol</source><volume>85</volume>(<issue>12</issue>):<fpage>5929</fpage>&#x02013;<lpage>5939</lpage><pub-id pub-id-type="pmid">21471240</pub-id></mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hennecke</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lohmann</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kayser</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neumann-Haefelin</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kukolj</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bocher</surname><given-names>WO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thimme</surname><given-names>R</given-names></name></person-group>
<year>2014</year>
<article-title>Restoration of HCV-specific CD8+ T cell function by interferon-free therapy</article-title>. <source>J Hepatol</source><volume>61</volume>(<issue>3</issue>):<fpage>538</fpage>&#x02013;<lpage>543</lpage><pub-id pub-id-type="pmid">24905492</pub-id></mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matzinger</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carroll</surname><given-names>TD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dutra</surname><given-names>JC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ma</surname><given-names>ZM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Miller</surname><given-names>CJ</given-names></name></person-group>
<year>2013</year>
<article-title>Myxovirus resistance gene A (MxA) expression suppresses influenza A virus replication in alpha interferon-treated primate cells</article-title>. <source>J Virol</source><volume>87</volume>(<issue>2</issue>):<fpage>1150</fpage>&#x02013;<lpage>1158</lpage><pub-id pub-id-type="pmid">23152507</pub-id></mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hieny</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Caspar</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oland</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sher</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Innate and adaptive interferons suppress IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection</article-title>. <source>Immunity</source><volume>35</volume>(<issue>6</issue>):<fpage>1023</fpage>&#x02013;<lpage>1034</lpage><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andrade</surname><given-names>BB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oland</surname><given-names>SD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Amaral</surname><given-names>EP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barber</surname><given-names>DL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gonzales</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Derrick</surname><given-names>SC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shi</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kumar</surname><given-names>NP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wei</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yuan</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Babu</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Catalfamo</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salazar</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Via</surname><given-names>LE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name></person-group>, <person-group person-group-type="author"><name><surname>Sher</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title>. <source>Nature</source><volume>511</volume>(<issue>7507</issue>):<fpage>99</fpage>&#x02013;<lpage>103</lpage><pub-id pub-id-type="pmid">24990750</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCullers</surname><given-names>JA</given-names></name></person-group>
<year>2014</year>
<article-title>The co-pathogenesis of influenza viruses with bacteria in the lung</article-title>. <source>Nat Rev Microbiol</source><volume>12</volume>(<issue>4</issue>):<fpage>252</fpage>&#x02013;<lpage>262</lpage><pub-id pub-id-type="pmid">24590244</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ewbank</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Howes</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moreira-Teixeira</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martirosyan</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghilardi</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saraiva</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages</article-title>. <source>J Immunol</source><volume>193</volume>(<issue>7</issue>):<fpage>3600</fpage>&#x02013;<lpage>3612</lpage><pub-id pub-id-type="pmid">25187652</pub-id></mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ewbank</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rajsbaum</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stavropoulos</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martirosyan</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graham</surname><given-names>CM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saraiva</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tsichlis</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chaussabel</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ley</surname><given-names>SC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group>
<year>2013</year>
<article-title>TPL-2-ERK1/2 signaling promotes host resistance against intracellular bacterial infection by negative regulation of type I IFN production</article-title>. <source>J Immunol</source><volume>191</volume>(<issue>4</issue>):<fpage>1732</fpage>&#x02013;<lpage>1743</lpage><pub-id pub-id-type="pmid">23842752</pub-id></mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Micco</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peppa</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Loggi</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schurich</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jefferson</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cursaro</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Panno</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bernardi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brander</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bihl</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andreone</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maini</surname><given-names>MK</given-names></name></person-group>
<year>2013</year>
<article-title>Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B</article-title>. <source>J Hepatol</source><volume>58</volume>(<issue>2</issue>):<fpage>225</fpage>&#x02013;<lpage>233</lpage><pub-id pub-id-type="pmid">23046671</pub-id></mixed-citation></ref><ref id="B84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Missale</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pilli</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zerbini</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Penna</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ravanetti</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barili</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Orlandini</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Molinari</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fasano</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Santantonio</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>C</given-names></name></person-group>
<year>2012</year>
<article-title>Lack of full CD8 functional restoration after antiviral treatment for acute and chronic hepatitis C virus infection</article-title>. <source>Gut</source><volume>61</volume>(<issue>7</issue>):<fpage>1076</fpage>&#x02013;<lpage>1084</lpage><pub-id pub-id-type="pmid">22337949</pub-id></mixed-citation></ref><ref id="B85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montoya</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schiavoni</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mattei</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gresser</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Belardelli</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borrow</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tough</surname><given-names>DF</given-names></name></person-group>
<year>2002</year>
<article-title>Type I interferons produced by dendritic cells promote their phenotypic and functional activation</article-title>. <source>Blood</source><volume>99</volume>(<issue>9</issue>):<fpage>3263</fpage>&#x02013;<lpage>3271</lpage><pub-id pub-id-type="pmid">11964292</pub-id></mixed-citation></ref><ref id="B86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordstein</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dumoutier</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Renauld</surname><given-names>JC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Paludan</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klucher</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>
<year>2008</year>
<article-title>Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses</article-title>. <source>PLoS Pathog</source><volume>4</volume>(<issue>9</issue>):<fpage>e1000151</fpage><pub-id pub-id-type="pmid">18787692</pub-id></mixed-citation></ref><ref id="B87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mordstein</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neugebauer</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ditt</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jessen</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rieger</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Falcone</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sorgeloos</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ehl</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mayer</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schwemmle</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gunther</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Drosten</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Michiels</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>
<year>2010</year>
<article-title>Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections</article-title>. <source>J Virol</source><volume>84</volume>(<issue>11</issue>):<fpage>5670</fpage>&#x02013;<lpage>5677</lpage><pub-id pub-id-type="pmid">20335250</pub-id></mixed-citation></ref><ref id="B88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>DM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taubenberger</surname><given-names>JK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group>
<year>2008</year>
<article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness</article-title>. <source>J Infect Dis</source><volume>198</volume>(<issue>7</issue>):<fpage>962</fpage>&#x02013;<lpage>970</lpage><pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="B89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Steinhoff</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reis</surname><given-names>LF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hemmi</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pavlovic</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aguet</surname><given-names>M</given-names></name></person-group>
<year>1994</year>
<article-title>Functional role of type I and type II interferons in antiviral defense</article-title>. <source>Science</source><volume>264</volume>(<issue>5167</issue>):<fpage>1918</fpage>&#x02013;<lpage>1921</lpage><pub-id pub-id-type="pmid">8009221</pub-id></mixed-citation></ref><ref id="B90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>PJ</given-names></name></person-group>
<year>2007</year>
<article-title>The JAK-STAT signaling pathway: input and output integration</article-title>. <source>J Immunol</source><volume>178</volume>(<issue>5</issue>):<fpage>2623</fpage>&#x02013;<lpage>2629</lpage><pub-id pub-id-type="pmid">17312100</pub-id></mixed-citation></ref><ref id="B91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Davis</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group>
<year>2011</year>
<article-title>Synergistic stimulation of type I interferons during influenza virus coinfection promotes <italic>Streptococcus pneumoniae</italic> colonization in mice</article-title>. <source>J Clin Invest</source><volume>121</volume>(<issue>9</issue>):<fpage>3657</fpage>&#x02013;<lpage>3665</lpage><pub-id pub-id-type="pmid">21841308</pub-id></mixed-citation></ref><ref id="B92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarini</surname><given-names>AA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Recher</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>KS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Georgiev</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meury</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bergthaler</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Flatz</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bille</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Landmann</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Odermatt</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hengartner</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group>
<year>2006</year>
<article-title>Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses</article-title>. <source>Proc Natl Acad Sci U S A</source><volume>103</volume>(<issue>42</issue>):<fpage>15535</fpage>&#x02013;<lpage>15539</lpage><pub-id pub-id-type="pmid">17030789</pub-id></mixed-citation></ref><ref id="B93"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cardone</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thompson</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shenderov</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kirschman</surname><given-names>KD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Myers</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rabin</surname><given-names>RL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sher</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Feng</surname><given-names>CG</given-names></name></person-group>
<year>2011</year>
<article-title>Mycobacterium tuberculosis triggers host type I IFN signaling to regulate IL-1beta production in human macrophages</article-title>. <source>J Immunol</source><volume>187</volume>(<issue>5</issue>):<fpage>2540</fpage>&#x02013;<lpage>2547</lpage><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="B94"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Manches</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>N</given-names></name></person-group>
<year>2013</year>
<article-title>Plasmacytoid dendritic cells in HIV infection</article-title>. <source>Adv Exp Med Biol</source><volume>762</volume>:<fpage>71</fpage>&#x02013;<lpage>107</lpage><pub-id pub-id-type="pmid">22975872</pub-id></mixed-citation></ref><ref id="B95"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Manches</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sabado</surname><given-names>RL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baranda</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marie</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rolnitzky</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Markowitz</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Margolis</surname><given-names>DM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levy</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>N</given-names></name></person-group>
<year>2011</year>
<article-title>Spatiotemporal trafficking of HIV in human plasmacytoid dendritic cells defines a persistently IFN-alpha-producing and partially matured phenotype</article-title>. <source>J Clin Invest</source><volume>121</volume>(<issue>3</issue>):<fpage>1088</fpage>&#x02013;<lpage>1101</lpage><pub-id pub-id-type="pmid">21339641</pub-id></mixed-citation></ref><ref id="B96"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Connell</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Saha</surname><given-names>SK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vaidya</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bruhn</surname><given-names>KW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Miranda</surname><given-names>GA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zarnegar</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perry</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>BO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lane</surname><given-names>TF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Miller</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>
<year>2004</year>
<article-title>Type I interferon production enhances susceptibility to Listeria monocytogenes infection</article-title>. <source>J Exp Med</source><volume>200</volume>(<issue>4</issue>):<fpage>437</fpage>&#x02013;<lpage>445</lpage><pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="B97"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlovic</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arzet</surname><given-names>HA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hefti</surname><given-names>HP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Frese</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rost</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ernst</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kolb</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name></person-group>
<year>1995</year>
<article-title>Enhanced virus resistance of transgenic mice expressing the human MxA protein</article-title>. <source>J Virol</source><volume>69</volume>(<issue>7</issue>):<fpage>4506</fpage>&#x02013;<lpage>4510</lpage><pub-id pub-id-type="pmid">7769712</pub-id></mixed-citation></ref><ref id="B98"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pavlovic</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>
<year>1992</year>
<article-title>Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle</article-title>. <source>J Virol</source><volume>66</volume>(<issue>4</issue>):<fpage>2564</fpage>&#x02013;<lpage>2569</lpage><pub-id pub-id-type="pmid">1548781</pub-id></mixed-citation></ref><ref id="B99"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peiris</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yu</surname><given-names>WC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leung</surname><given-names>CW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheung</surname><given-names>CY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ng</surname><given-names>WF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nicholls</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ng</surname><given-names>TK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chan</surname><given-names>KH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lai</surname><given-names>ST</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lim</surname><given-names>WL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yuen</surname><given-names>KY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guan</surname><given-names>Y</given-names></name></person-group>
<year>2004</year>
<article-title>Re-emergence of fatal human influenza A subtype H5N1 disease</article-title>. <source>Lancet</source><volume>363</volume>(<issue>9409</issue>):<fpage>617</fpage>&#x02013;<lpage>619</lpage><pub-id pub-id-type="pmid">14987888</pub-id></mixed-citation></ref><ref id="B100"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penna</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laccabue</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Libri</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Giuberti</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schivazappa</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alfieri</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mori</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Canetti</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lampertico</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vigano</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Colombo</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Loggi</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Missale</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ferrari</surname><given-names>C</given-names></name></person-group>
<year>2012</year>
<article-title>Peginterferon-alpha does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis</article-title>. <source>J Hepatol</source><volume>56</volume>(<issue>6</issue>):<fpage>1239</fpage>&#x02013;<lpage>1246</lpage><pub-id pub-id-type="pmid">22326467</pub-id></mixed-citation></ref><ref id="B101"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peppa</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gill</surname><given-names>US</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Easom</surname><given-names>NJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pallett</surname><given-names>LJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schurich</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Micco</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nebbia</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Singh</surname><given-names>HD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Adams</surname><given-names>DH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>PT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maini</surname><given-names>MK</given-names></name></person-group>
<year>2013</year>
<article-title>Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion</article-title>. <source>J Exp Med</source><volume>210</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>114</lpage><pub-id pub-id-type="pmid">23254287</pub-id></mixed-citation></ref><ref id="B102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krause</surname><given-names>CD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Walter</surname><given-names>MR</given-names></name></person-group>
<year>2004</year>
<article-title>Interferons, interferon-like cytokines, and their receptors</article-title>. <source>Immunol Rev</source><volume>202</volume>:<fpage>8</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="pmid">15546383</pub-id></mixed-citation></ref><ref id="B103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piehler</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roisman</surname><given-names>LC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2000</year>
<article-title>New structural and functional aspects of the type I interferon-receptor interaction revealed by comprehensive mutational analysis of the binding interface</article-title>. <source>J Biol Chem</source><volume>275</volume>(<issue>51</issue>):<fpage>40425</fpage>&#x02013;<lpage>40433</lpage><pub-id pub-id-type="pmid">10984492</pub-id></mixed-citation></ref><ref id="B104"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piehler</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia</surname><given-names>KC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2012</year>
<article-title>Structural and dynamic determinants of type I interferon receptor assembly and their functional interpretation</article-title>. <source>Immunol Rev</source><volume>250</volume>(<issue>1</issue>):<fpage>317</fpage>&#x02013;<lpage>334</lpage><pub-id pub-id-type="pmid">23046138</pub-id></mixed-citation></ref><ref id="B105"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Daffis</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brien</surname><given-names>JD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gainey</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>KC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Murphy</surname><given-names>KM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Diamond</surname><given-names>MS</given-names></name></person-group>
<year>2011</year>
<article-title>A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection</article-title>. <source>PLoS Pathog</source><volume>7</volume>(<issue>12</issue>):<fpage>e1002407</fpage><pub-id pub-id-type="pmid">22144897</pub-id></mixed-citation></ref><ref id="B106"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname><given-names>GE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gaszewska-Mastarlarz</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moskophidis</surname><given-names>D</given-names></name></person-group>
<year>2000</year>
<article-title>The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice</article-title>. <source>J Virol</source><volume>74</volume>(<issue>9</issue>):<fpage>3996</fpage>&#x02013;<lpage>4003</lpage><pub-id pub-id-type="pmid">10756011</pub-id></mixed-citation></ref><ref id="B107"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajasuriar</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khoury</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kamarulzaman</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>French</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cameron</surname><given-names>PU</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewin</surname><given-names>SR</given-names></name></person-group>
<year>2013</year>
<article-title>Persistent immune activation in chronic HIV infection: do any interventions work?</article-title><source>AIDS</source><volume>27</volume>(<issue>8</issue>):<fpage>1199</fpage>&#x02013;<lpage>1208</lpage><pub-id pub-id-type="pmid">23324661</pub-id></mixed-citation></ref><ref id="B108"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Humann</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Penheiter</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Andreasen</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<year>2010</year>
<article-title>Induction of IFN-alphabeta enables Listeria monocytogenes to suppress macrophage activation by IFN-gamma</article-title>. <source>J Exp Med</source><volume>207</volume>(<issue>2</issue>):<fpage>327</fpage>&#x02013;<lpage>337</lpage><pub-id pub-id-type="pmid">20123961</pub-id></mixed-citation></ref><ref id="B109"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stavropoulos</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wack</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sher</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Garra</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway</article-title>. <source>J Infect Dis</source><volume>209</volume>(<issue>2</issue>):<fpage>270</fpage>&#x02013;<lpage>274</lpage><pub-id pub-id-type="pmid">23935205</pub-id></mixed-citation></ref><ref id="B110"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roisman</surname><given-names>LC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaitin</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baker</surname><given-names>DP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>
<year>2005</year>
<article-title>Mutational analysis of the IFNAR1 binding site on IFNalpha2 reveals the architecture of a weak ligand-receptor binding-site</article-title>. <source>J Mol Biol</source><volume>353</volume>(<issue>2</issue>):<fpage>271</fpage>&#x02013;<lpage>281</lpage><pub-id pub-id-type="pmid">16171819</pub-id></mixed-citation></ref><ref id="B111"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rotger</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dalmau</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rauch</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McLaren</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bosinger</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martinez</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sandler</surname><given-names>NG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roque</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liebner</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Battegay</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bernasconi</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Descombes</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Erkizia</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fellay</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hirschel</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Miro</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Palou</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Massanella</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Blanco</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Woods</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gunthard</surname><given-names>HF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de Bakker</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Douek</surname><given-names>DC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Silvestri</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martinez-Picado</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Telenti</surname><given-names>A</given-names></name></person-group>
<year>2011</year>
<article-title>Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque</article-title>. <source>J Clin Invest</source><volume>121</volume>(<issue>6</issue>):<fpage>2391</fpage>&#x02013;<lpage>2400</lpage><pub-id pub-id-type="pmid">21555857</pub-id></mixed-citation></ref><ref id="B112"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadler</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williams</surname><given-names>BR</given-names></name></person-group>
<year>2008</year>
<article-title>Interferon-inducible antiviral effectors</article-title>. <source>Nat Rev Immunol</source><volume>8</volume>(<issue>7</issue>):<fpage>559</fpage>&#x02013;<lpage>568</lpage><pub-id pub-id-type="pmid">18575461</pub-id></mixed-citation></ref><ref id="B113"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samarajiwa</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Forster</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Auchettl</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hertzog</surname><given-names>PJ</given-names></name></person-group>
<year>2009</year>
<article-title>INTERFEROME: the database of interferon regulated genes</article-title>. <source>Nucleic Acids Res</source><volume>37</volume>(<issue>Database issue</issue>):<fpage>D852</fpage>&#x02013;<lpage>D857</lpage><pub-id pub-id-type="pmid">18996892</pub-id></mixed-citation></ref><ref id="B114"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaefer</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Voloshanenko</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Willen</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Walczak</surname><given-names>H</given-names></name></person-group>
<year>2007</year>
<article-title>TRAIL: a multifunctional cytokine</article-title>. <source>Front Biosci</source><volume>12</volume>:<fpage>3813</fpage>&#x02013;<lpage>3824</lpage><pub-id pub-id-type="pmid">17485341</pub-id></mixed-citation></ref><ref id="B115"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schickli</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaur</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ulbrandt</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Spaete</surname><given-names>RR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tang</surname><given-names>RS</given-names></name></person-group>
<year>2005</year>
<article-title>An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters</article-title>. <source>J Virol</source><volume>79</volume>(<issue>16</issue>):<fpage>10678</fpage>&#x02013;<lpage>10689</lpage><pub-id pub-id-type="pmid">16051860</pub-id></mixed-citation></ref><ref id="B116"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schliehe</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Flynn</surname><given-names>EK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vilagos</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Richson</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Swaminathan</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bosnjak</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bauer</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kandasamy</surname><given-names>RK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Griesshammer</surname><given-names>IM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kosack</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schmitz</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Litvak</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sissons</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lercher</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bhattacharya</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Khamina</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trivett</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tessarollo</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mesteri</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hladik</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Merkler</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kubicek</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Knapp</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Epstein</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Symer</surname><given-names>DE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aderem</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bergthaler</surname><given-names>A</given-names></name></person-group>
<year>2015</year>
<article-title>The methyltransferase Setdb2 mediates virus-induced susceptibility to bacterial superinfection</article-title>. <source>Nat Immunol</source><volume>16</volume>(<issue>1</issue>):<fpage>67</fpage>&#x02013;<lpage>74</lpage><pub-id pub-id-type="pmid">25419628</pub-id></mixed-citation></ref><ref id="B117"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>WM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chevillotte</surname><given-names>MD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rice</surname><given-names>CM</given-names></name></person-group>
<year>2014</year>
<article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu Rev Immunol</source><volume>32</volume>:<fpage>513</fpage>&#x02013;<lpage>545</lpage><pub-id pub-id-type="pmid">24555472</pub-id></mixed-citation></ref><ref id="B118"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoggins</surname><given-names>JW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rice</surname><given-names>CM</given-names></name></person-group>
<year>2011</year>
<article-title>Interferon-stimulated genes and their antiviral effector functions</article-title>. <source>Curr Opin Virol</source><volume>1</volume>(<issue>6</issue>):<fpage>519</fpage>&#x02013;<lpage>525</lpage><pub-id pub-id-type="pmid">22328912</pub-id></mixed-citation></ref><ref id="B119"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schusser</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reuter</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>von der Malsburg</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Penski</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weigend</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kaspers</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hartle</surname><given-names>S</given-names></name></person-group>
<year>2011</year>
<article-title>Mx is dispensable for interferon-mediated resistance of chicken cells against influenza A virus</article-title>. <source>J Virol</source><volume>85</volume>(<issue>16</issue>):<fpage>8307</fpage>&#x02013;<lpage>8315</lpage><pub-id pub-id-type="pmid">21632756</pub-id></mixed-citation></ref><ref id="B120"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seo</surname><given-names>SU</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kwon</surname><given-names>HJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ko</surname><given-names>HJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Byun</surname><given-names>YH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Seong</surname><given-names>BL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Uematsu</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Akira</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kweon</surname><given-names>MN</given-names></name></person-group>
<year>2011</year>
<article-title>Type I interferon signaling regulates Ly6C(hi) monocytes and neutrophils during acute viral pneumonia in mice</article-title>. <source>PLoS Pathog</source><volume>7</volume>(<issue>2</issue>):<fpage>e1001304</fpage><pub-id pub-id-type="pmid">21383977</pub-id></mixed-citation></ref><ref id="B121"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chow</surname><given-names>EK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tian</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kang</surname><given-names>JR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ghaffari</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>SY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Belperio</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Deng</surname><given-names>JC</given-names></name></person-group>
<year>2009</year>
<article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source>J Clin Invest</source><volume>119</volume>(<issue>7</issue>):<fpage>1910</fpage>&#x02013;<lpage>1920</lpage><pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="B122"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheppard</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kindsvogel</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Henderson</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schlutsmeyer</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Whitmore</surname><given-names>TE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kuestner</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garrigues</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Birks</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Roraback</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ostrander</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dong</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shin</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Presnell</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fox</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haldeman</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cooper</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taft</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grant</surname><given-names>FJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tackett</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krivan</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McKnight</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Clegg</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Foster</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klucher</surname><given-names>KM</given-names></name></person-group>
<year>2003</year>
<article-title>IL-28, IL-29 and their class II cytokine receptor IL-28R</article-title>. <source>Nat Immunol</source><volume>4</volume>(<issue>1</issue>):<fpage>63</fpage>&#x02013;<lpage>68</lpage><pub-id pub-id-type="pmid">12469119</pub-id></mixed-citation></ref><ref id="B123"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shiow</surname><given-names>LR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rosen</surname><given-names>DB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brdickova</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>An</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lanier</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cyster</surname><given-names>JG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matloubian</surname><given-names>M</given-names></name></person-group>
<year>2006</year>
<article-title>CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs</article-title>. <source>Nature</source><volume>440</volume>(<issue>7083</issue>):<fpage>540</fpage>&#x02013;<lpage>544</lpage><pub-id pub-id-type="pmid">16525420</pub-id></mixed-citation></ref><ref id="B124"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solis</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nakhaei</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jalalirad</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lacoste</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Douville</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Arguello</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laughrea</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wainberg</surname><given-names>MA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hiscott</surname><given-names>J</given-names></name></person-group>
<year>2011</year>
<article-title>RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I</article-title>. <source>J Virol</source><volume>85</volume>(<issue>3</issue>):<fpage>1224</fpage>&#x02013;<lpage>1236</lpage><pub-id pub-id-type="pmid">21084468</pub-id></mixed-citation></ref><ref id="B125"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommereyns</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Paul</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Michiels</surname><given-names>T</given-names></name></person-group>
<year>2008</year>
<article-title>IFN-lambda (IFN-lambda) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells <italic>in vivo</italic></article-title>. <source>PLoS Pathog</source><volume>4</volume>(<issue>3</issue>):<fpage>e1000017</fpage><pub-id pub-id-type="pmid">18369468</pub-id></mixed-citation></ref><ref id="B126"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stacey</surname><given-names>AR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Norris</surname><given-names>PJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qin</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haygreen</surname><given-names>EA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Taylor</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Heitman</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lebedeva</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>DeCamp</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grove</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Self</surname><given-names>SG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Borrow</surname><given-names>P</given-names></name></person-group>
<year>2009</year>
<article-title>Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections</article-title>. <source>J Virol</source><volume>83</volume>(<issue>8</issue>):<fpage>3719</fpage>&#x02013;<lpage>3733</lpage><pub-id pub-id-type="pmid">19176632</pub-id></mixed-citation></ref><ref id="B127"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stary</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klein</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kohlhofer</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Koszik</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Scherzer</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mullauer</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quendler</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kohrgruber</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stingl</surname><given-names>G</given-names></name></person-group>
<year>2009</year>
<article-title>Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients</article-title>. <source>Blood</source><volume>114</volume>(<issue>18</issue>):<fpage>3854</fpage>&#x02013;<lpage>3863</lpage><pub-id pub-id-type="pmid">19690337</pub-id></mixed-citation></ref><ref id="B128"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stegmann</surname><given-names>KA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bjorkstrom</surname><given-names>NK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Veber</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ciesek</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Riese</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wiegand</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hadem</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Suneetha</surname><given-names>PV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaroszewicz</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schlaphoff</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fytili</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cornberg</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Manns</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Geffers</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pietschmann</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Guzman</surname><given-names>CA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ljunggren</surname><given-names>HG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wedemeyer</surname><given-names>H</given-names></name></person-group>
<year>2010</year>
<article-title>Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection</article-title>. <source>Gastroenterology</source><volume>138</volume>(<issue>5</issue>):<fpage>1885</fpage>&#x02013;<lpage>1897</lpage><pub-id pub-id-type="pmid">20334827</pub-id></mixed-citation></ref><ref id="B129"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szretter</surname><given-names>KJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gangappa</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Belser</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zeng</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Matsuoka</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sambhara</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Swayne</surname><given-names>DE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katz</surname><given-names>JM</given-names></name></person-group>
<year>2009</year>
<article-title>Early control of H5N1 influenza virus replication by the type I interferon response in mice</article-title>. <source>J Virol</source><volume>83</volume>(<issue>11</issue>):<fpage>5825</fpage>&#x02013;<lpage>5834</lpage><pub-id pub-id-type="pmid">19297490</pub-id></mixed-citation></ref><ref id="B130"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>JR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ng</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>BM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sheehan</surname><given-names>KC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welch</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>de la Torre</surname><given-names>JC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Oldstone</surname><given-names>MB</given-names></name></person-group>
<year>2013</year>
<article-title>Persistent LCMV infection is controlled by blockade of type I interferon signaling</article-title>. <source>Science</source><volume>340</volume>(<issue>6129</issue>):<fpage>207</fpage>&#x02013;<lpage>211</lpage><pub-id pub-id-type="pmid">23580529</pub-id></mixed-citation></ref><ref id="B131"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graeber</surname><given-names>TG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krutzik</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Montoya</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schenk</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>DJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Komisopoulou</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kelly-Scumpia</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chun</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Iyer</surname><given-names>SS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sarno</surname><given-names>EN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rea</surname><given-names>TH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hewison</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Adams</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Popper</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Relman</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stenger</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Modlin</surname><given-names>RL</given-names></name></person-group>
<year>2013</year>
<article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source><volume>339</volume>(<issue>6126</issue>):<fpage>1448</fpage>&#x02013;<lpage>1453</lpage><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="B132"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moraga</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Levin</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Krutzik</surname><given-names>PO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Podoplelova</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Trejo</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yarden</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vleck</surname><given-names>SE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Glenn</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nolan</surname><given-names>GP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Piehler</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiber</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia</surname><given-names>KC</given-names></name></person-group>
<year>2011</year>
<article-title>Structural linkage between ligand discrimination and receptor activation by type I interferons</article-title>. <source>Cell</source><volume>146</volume>(<issue>4</issue>):<fpage>621</fpage>&#x02013;<lpage>632</lpage><pub-id pub-id-type="pmid">21854986</pub-id></mixed-citation></ref><ref id="B133"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name></person-group>
<year>2010</year>
<article-title>Type I interferon: friend or foe?</article-title><source>J Exp Med</source><volume>207</volume>(<issue>10</issue>):<fpage>2053</fpage>&#x02013;<lpage>2063</lpage><pub-id pub-id-type="pmid">20837696</pub-id></mixed-citation></ref><ref id="B134"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Szretter</surname><given-names>KJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Van Hoeven</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katz</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kochs</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haller</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Staeheli</surname><given-names>P</given-names></name></person-group>
<year>2007</year>
<article-title>The Mx1 gene protects mice against the pandemic 1918 and highly lethal human H5N1 influenza viruses</article-title>. <source>J Virol</source><volume>81</volume>(<issue>19</issue>):<fpage>10818</fpage>&#x02013;<lpage>10821</lpage><pub-id pub-id-type="pmid">17652381</pub-id></mixed-citation></ref><ref id="B135"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urban</surname><given-names>SL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>
<year>2014</year>
<article-title>Out-of-sequence signal 3 as a mechanism for virus-induced immune suppression of CD8 T cell responses</article-title>. <source>PLoS Pathog</source><volume>10</volume>(<issue>9</issue>):<fpage>e1004357</fpage><pub-id pub-id-type="pmid">25255454</pub-id></mixed-citation></ref><ref id="B136"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waggoner</surname><given-names>SN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cornberg</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Selin</surname><given-names>LK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>
<year>2012</year>
<article-title>Natural killer cells act as rheostats modulating antiviral T cells</article-title>. <source>Nature</source><volume>481</volume>(<issue>7381</issue>):<fpage>394</fpage>&#x02013;<lpage>398</lpage><pub-id pub-id-type="pmid">22101430</pub-id></mixed-citation></ref><ref id="B137"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bahl</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marshall</surname><given-names>HD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Urban</surname><given-names>SL</given-names></name></person-group>
<year>2012</year>
<article-title>Type 1 interferons and antiviral CD8 T-cell responses</article-title>. <source>PLoS Pathog</source><volume>8</volume>(<issue>1</issue>):<fpage>e1002352</fpage><pub-id pub-id-type="pmid">22241987</pub-id></mixed-citation></ref><ref id="B138"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wetzel</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fensterl</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sen</surname><given-names>GC</given-names></name></person-group>
<year>2014</year>
<article-title>Sendai virus pathogenesis in mice is prevented by ifit2 and exacerbated by interferon</article-title>. <source>J Virol</source><volume>88</volume>(<issue>23</issue>):<fpage>13593</fpage>&#x02013;<lpage>13601</lpage><pub-id pub-id-type="pmid">25231314</pub-id></mixed-citation></ref><ref id="B139"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yamada</surname><given-names>DH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Elsaesser</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Herskovitz</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Deng</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aronow</surname><given-names>BJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Karp</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brooks</surname><given-names>DG</given-names></name></person-group>
<year>2013</year>
<article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title>. <source>Science</source><volume>340</volume>(<issue>6129</issue>):<fpage>202</fpage>&#x02013;<lpage>207</lpage><pub-id pub-id-type="pmid">23580528</pub-id></mixed-citation></ref><ref id="B140"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>HC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Grusdat</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pandyra</surname><given-names>AA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Polz</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sharma</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Deenen</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kohrer</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rahbar</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Diefenbach</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gibbert</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lohning</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hocker</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Waibler</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haussinger</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mak</surname><given-names>TW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ohashi</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>KS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lang</surname><given-names>PA</given-names></name></person-group>
<year>2014</year>
<article-title>Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity</article-title>. <source>Immunity</source><volume>40</volume>(<issue>6</issue>):<fpage>949</fpage>&#x02013;<lpage>960</lpage><pub-id pub-id-type="pmid">24909887</pub-id></mixed-citation></ref><ref id="B141"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>XJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reichner</surname><given-names>JS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mastrofrancesco</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Henry</surname><given-names>WL</given-names><suffix>Jr.</suffix></name></person-group>, <person-group person-group-type="author"><name><surname>Albina</surname><given-names>JE</given-names></name></person-group>
<year>2008</year>
<article-title>Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production</article-title>. <source>J Immunol</source><volume>180</volume>(<issue>4</issue>):<fpage>2125</fpage>&#x02013;<lpage>2131</lpage><pub-id pub-id-type="pmid">18250418</pub-id></mixed-citation></ref><ref id="B142"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Goldsmith</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thawatsupha</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chittaganpitch</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Waicharoen</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zaki</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tumpey</surname><given-names>TM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Katz</surname><given-names>JM</given-names></name></person-group>
<year>2007</year>
<article-title>Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type i interferon response in polarized human bronchial epithelial cells</article-title>. <source>J Virol</source><volume>81</volume>(<issue>22</issue>):<fpage>12439</fpage>&#x02013;<lpage>12449</lpage><pub-id pub-id-type="pmid">17855549</pub-id></mixed-citation></ref></